
Sign up to save your podcasts
Or


The use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast.
We hope you enjoy the #FGPodcast. Please follow @FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on Apple Podcasts: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229
By BMJ GroupThe use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast.
We hope you enjoy the #FGPodcast. Please follow @FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on Apple Podcasts: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229

135 Listeners

543 Listeners

495 Listeners

37 Listeners

50 Listeners

69 Listeners

5 Listeners

8 Listeners

5 Listeners

3 Listeners

2 Listeners

3 Listeners

8 Listeners

38 Listeners

14 Listeners

1 Listeners

51 Listeners

6 Listeners

14 Listeners

139 Listeners

3 Listeners

3,338 Listeners

3 Listeners

23 Listeners

1,153 Listeners

195 Listeners

703 Listeners

24 Listeners

23 Listeners

833 Listeners

18 Listeners